United States · Funded startup

Who invested in Werewolf Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2022, from 1 source

Latest round
Secondary, $50MMay 2022
Investors
4
See who backed them

The rounds

  1. May 2022

Founders and team

From the SEC filings it signed: 2 on the team.

  • Daniel HicklinExecutive Officer, Directori
  • David CordoExecutive Officeri

On the board, as filediAlon LazarusBriggs MorrisonDerek DiRoccoElise WangLuke EvninSakae Asanuma

Everyone who backed them

RA Capital ManagementPrivate equity1round
DeerfieldVC firm1round
Adage Capital ManagementAsset manager1round
Longwood FundVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Werewolf Therapeutics

Who invested in Werewolf Therapeutics?

Werewolf Therapeutics's investors include RA Capital Management, Deerfield, Adage Capital Management and Longwood Fund.

How much has Werewolf Therapeutics raised?

Werewolf Therapeutics has raised $50M across 1 round since 2022.

When did Werewolf Therapeutics last raise?

Werewolf Therapeutics's most recent round was a Secondary of $50M in May 2022.

What was Werewolf Therapeutics's biggest round?

Its most recent round, $50M in May 2022, is also its largest on record.

Who backed Werewolf Therapeutics first?

Werewolf Therapeutics's first round on record, in May 2022, was backed by RA Capital Management, Deerfield and Adage Capital Management and 1 others.

What stage is Werewolf Therapeutics at?

Werewolf Therapeutics's latest named round is a Secondary, in May 2022.

Where is Werewolf Therapeutics based?

Werewolf Therapeutics is based in the United States.

Companies like Werewolf Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.